BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 25326405)

  • 1. Serum hyaluronic acid in polymyositis: high serum levels tend to correlate with disease activity.
    Silva MB; Silva MG; Shinjo SK
    Acta Reumatol Port; 2014; 39(3):248-53. PubMed ID: 25326405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of serum hyaluronic acid in adults with dermatomyositis.
    Victorino AA; Silva MG; Shinjo SK
    Acta Reumatol Port; 2015; 40(2):150-5. PubMed ID: 26219968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid in dermatomyositis and polymyositis: relationship with disease and cutaneous lesions.
    Silva MG; Shinjo SK
    An Bras Dermatol; 2018; 93(1):72-75. PubMed ID: 29641701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The high prevalence of metabolic syndrome in polymyositis.
    de Souza FH; Shinjo SK
    Clin Exp Rheumatol; 2014; 32(1):82-7. PubMed ID: 24144101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Serum Levels of Soluble CD163 in Polymyositis and Dermatomyositis: Associated with Macrophage Infiltration in Muscle Tissue.
    Peng QL; Zhang YL; Shu XM; Yang HB; Zhang L; Chen F; Lu X; Wang GC
    J Rheumatol; 2015 Jun; 42(6):979-87. PubMed ID: 25877505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum interleukin-17A level is associated with disease activity of adult patients with dermatomyositis and polymyositis.
    Silva MG; Oba-Shinjo SM; Marie SKN; Shinjo SK
    Clin Exp Rheumatol; 2019; 37(4):656-662. PubMed ID: 30620283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum hyaluronic acid as a marker of hepatic fibrosis.
    Khan JA; Khan FA; Dilawar M; Ijaz A; Khan NA; Mehmood T
    J Coll Physicians Surg Pak; 2007 Jun; 17(6):323-6. PubMed ID: 17623578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The levels and clinical significance of serum B cell activating factor in Chinese patients with polymyositis or dermatomyositis].
    Peng QL; Xie Y; Zhang RF; Shu XM; Wang GC
    Zhonghua Nei Ke Za Zhi; 2012 Mar; 51(3):210-3. PubMed ID: 22781895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.
    Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D; Fard MK; Agcheli K
    J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-cell activating factor as a serological biomarker for polymyositis and dermatomyositis.
    Peng QL; Shu XM; Wang DX; Wang Y; Lu X; Wang GC
    Biomark Med; 2014; 8(3):395-403. PubMed ID: 24712431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of serum hyaluronic acid in patients with rheumatoid arthritis: correlation with disease activity.
    Emlen W; Niebur J; Flanders G; Rutledge J
    J Rheumatol; 1996 Jun; 23(6):974-8. PubMed ID: 8782125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary involvement in polymyositis and in dermatomyositis.
    Marie I; Hatron PY; Hachulla E; Wallaert B; Michon-Pasturel U; Devulder B
    J Rheumatol; 1998 Jul; 25(7):1336-43. PubMed ID: 9676766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potential clinical usefulness of measuring serum bilirubin levels in patients with polymyositis.
    Peng YF; Zhang L; Pan GG; Wei YS
    Eur Rev Med Pharmacol Sci; 2016; 20(4):631-5. PubMed ID: 26957263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between serum hyaluronic acid level and disease activity in early rheumatoid arthritis.
    Majeed M; McQueen F; Yeoman S; McLean L
    Ann Rheum Dis; 2004 Sep; 63(9):1166-8. PubMed ID: 15308530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of serum markers for the development of interstitial lung disease in patients with polymyositis and dermatomyositis: a comparative and prospective study.
    Chen F; Lu X; Shu X; Peng Q; Tian X; Wang G
    Intern Med J; 2015 Jun; 45(6):641-7. PubMed ID: 25827843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum hyaluronic acid level does not reliably differentiate minimal and significant liver disease in chronic hepatitis C.
    Arain SA; Meo SA; Jamal Q
    Saudi Med J; 2011 Dec; 32(12):1241-5. PubMed ID: 22159377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of liver fibrosis development in chronic hepatitis B patients by serum hyaluronic acid and laminin levels.
    Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D
    Acta Clin Croat; 2010 Sep; 49(3):257-65. PubMed ID: 21462814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic acid predicts hepatic fibrosis in children with hepatic disease.
    Hartley JL; Brown RM; Tybulewicz A; Hayes P; Wilson DC; Gillett P; McKiernan P
    J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):217-21. PubMed ID: 16877988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of hyaluronic acid indicate the severity of joint symptoms in patients with systemic and polyarticular juvenile rheumatoid arthritis.
    Takei S; Imanaka H; Maeno N; Shigemori M; Masuda K; Hokonohara M; Miyata K
    J Rheumatol; 1996 Nov; 23(11):1956-62. PubMed ID: 8923375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between serum levels of IL-15 and IL-17 in patients with idiopathic inflammatory myopathies.
    Notarnicola A; Lapadula G; Natuzzi D; Lundberg IE; Iannone F
    Scand J Rheumatol; 2015 May; 44(3):224-8. PubMed ID: 25379698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.